Nashville, TNNCT06852950Now EnrollingIRB Ready

Type 2 Diabetes Mellitus (T2DM) Clinical Trial in Nashville, TN

Access cutting-edge type 2 diabetes mellitus (t2dm) treatment through this clinical trial at a research site in Nashville. Study-provided care at no cost to qualified participants.

Sponsored by Vanderbilt University Medical Center

Quick Self-Assessment

See if you qualify for this Nashville location

Preparing your pre-screening questions…

Expert Care in Nashville

Access type 2 diabetes mellitus (t2dm) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 2 diabetes mellitus (t2dm) treatment provided free

Apply for This Nashville Location

Check if you qualify for this type 2 diabetes mellitus (t2dm) clinical trial in Nashville, TN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Nashville

    Convenient for TN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Nashville site if eligible
  4. 4Begin participation

About This Type 2 Diabetes Mellitus (T2DM) Study in Nashville

This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.

Sponsor: Vanderbilt University Medical Center

Who Can Participate

Inclusion Criteria

Non-pregnant adults, ages greater than or equal to 18 years, admitted to VUMC
Able to give informed consent
Hyperglycemia requiring insulin therapy including subcutaneous insulin injection or continuous subcutaneous insulin infusion (patient's own insulin pump) during hospitalization and at the time of discharge
POC glucose or venous glucose levels in the 24 hours prior to participation need to be 70-350 mg/dL
Need glucose readings greater than or equal to one time per day
Mental status and dexterity adequate to use Libre 3 Plus or Dexcom G7 sensors with Libre 3 or Dexcom G7 application on patient's smartphone

Exclusion Criteria

Currently using Libre 3 Plus or Dexcom G7 CGMS during hospitalization or have used Libre 3 Plus or Dexcom G7 CGMS in the past 3 months
Does not have smartphone compatible with Libre 3 App or Dexcom G7 App
Received chemotherapy during current hospitalization
Planning on major surgery within 10-15 days
Hemodialysis or peritoneal dialysis
Requiring vasopressors, intubation, sedation, or admission to an intensive care unit
Vitamin C use of more than 500 milligrams per day
Hydroxyurea use
Acetaminophen use of more than 4 grams per day or 1 gram every 6 hours
Significant pitting edema (3+ or greater) i.e. cirrhosis with ascites, congestive heart failure with edema, nephrotic syndrome, or signs of poor perfusion
Presentation in diabetic ketoacidosis or hyperosmotic nonketotic state
Skin allergy to adhesives

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Nashville?

Yes, this clinical trial (NCT06852950) has an active research site in Nashville, TN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 2 Diabetes Mellitus (T2DM) Treatment Options in Nashville, TN

If you're searching for type 2 diabetes mellitus (t2dm) treatment options in Nashville, TN, this clinical trial (NCT06852950) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Nashville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes mellitus (t2dm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 2 diabetes mellitus (t2dm) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Nashville, TN

See all pulmonary embolism clinical trials recruiting in Nashville — not just this study.

Browse Pulmonary Embolism Trials in Nashville →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 2 Diabetes TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Nashville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Nashville, TN